🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

BRIEF-Immuron North American Travelan Sales Up 95%, Global Sales Up 60%

Published 20/04/2020, 08:29 pm
© Reuters.
IMC
-

April 20 (Reuters) - Immuron Ltd IMC.AX :

* IMMURON NORTH AMERICAN TRAVELAN® SALES UP 95%, GLOBAL SALES UP 60%

* IMMURON LTD - ANTICIPATED THAT COVID-19 TRAVEL RESTRICTIONS WILL IMPACT TRAVELAN SALES IN Q4 OF FY20

* IMMURON LTD - WILL LOOK TO INCREASE OVERALL REVENUES TO HELP MITIGATE ANTICIPATED DECREASE IN TRAVELAN SALES

* IMMURON LTD - DECIDED TO CONSERVE UR CASH RESERVES

* IMMURON - SUSPENDING ALL WORK ASSOCIATED WITH IND FILING AND POSTPONING PLANNED PHASE III CLINICAL PROGRAM FOR IMM-124E TO PREVENT TRAVELERS' DIARRHEA

* IMMURON LTD - DECISION WILL ALSO IMPACT PLANNED CLINICAL DEVELOPMENT OF OUR IMM-529 ASSET

* IMMURON - WILL CONTINUE DEVELOPMENT OF NEW ORAL THERAPEUTIC TARGETING TRAVELERS' DIARRHEA CAUSED BY CAMPYLOBACTER, ENTEROTOXIGENIC E.COLI PATHOGENS

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.